NACGGANAAA (SEQ ID NO: 1), where N is a modified nucleoside base, and the stem includes at least 3 nucleotide base-pairs and one of the nucleotides in the stem includes a modified nucleoside base, wherein the modified nucleoside base has the structure -B-L-A where A is a branched-chain Man9 oligosaccharide, L is a linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are also disclosed."/> GLYCOSYLATED OLIGONUCLEOTIDES THAT MIMIC THE HIV-1 EPITOPE OF NEUTRALIZING MONOCLONAL ANTIBODY 2G12
首页> 外国专利> GLYCOSYLATED OLIGONUCLEOTIDES THAT MIMIC THE HIV-1 EPITOPE OF NEUTRALIZING MONOCLONAL ANTIBODY 2G12

GLYCOSYLATED OLIGONUCLEOTIDES THAT MIMIC THE HIV-1 EPITOPE OF NEUTRALIZING MONOCLONAL ANTIBODY 2G12

机译:模拟中和单克隆抗体2G12的HIV-1表位的糖基化寡核苷酸

摘要

Disclosed are oligonucleotides that binds specifically to HIV neutralizing monoclonal antibody 2G12 with a K4 value lower than 20 nM, the oligonucleotide comprising a predicted structure, at 37° C., having exactly one stem-loop whereby the loop comprises the nucleotide sequence of AACCNACGGANAAA (SEQ ID NO: 1), where N is a modified nucleoside base, and the stem includes at least 3 nucleotide base-pairs and one of the nucleotides in the stem includes a modified nucleoside base, wherein the modified nucleoside base has the structure -B-L-A where A is a branched-chain Man9 oligosaccharide, L is a linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are also disclosed.
机译:公开了一种寡核苷酸,其以低于20nM的K 4 值特异性结合HIV中和性单克隆抗体2G12,所述寡核苷酸在37℃下具有预测的结构,具有恰好一个茎环,由此环包含AACC N ACGGA N AAA(SEQ ID NO:1)的核苷酸序列,其中 N 是修饰的核苷碱基,并且茎干包含至少3个核苷酸碱基对,茎干中的一个核苷酸包含修饰的核苷碱基,其中,修饰的核苷碱基具有-BLA结构,其中A是一个分支的Man 9 寡糖,L是一个连接分子,B独立地是一个与寡核苷酸的糖磷酸骨架相连的嘧啶或吡啶碱基。还公开了包括寡核苷酸的免疫原性缀合物,以及包括寡核苷酸或免疫原性缀合物的药物组合物。还公开了使用寡核苷酸,免疫原性缀合物和药物组合物的各种方法。

著录项

  • 公开/公告号US2019117748A1

    专利类型

  • 公开/公告日2019-04-25

    原文格式PDF

  • 申请/专利权人 BRANDEIS UNIVERSITY;

    申请/专利号US201716092137

  • 发明设计人 ISAAC J. KRAUSS;JOEL SEBASTIAN TEMME;

    申请日2017-04-06

  • 分类号A61K39;C12N15/117;C07H15/22;A61K39/39;C12N15/115;A61P31/18;

  • 国家 US

  • 入库时间 2022-08-21 12:08:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号